Evidence map›Paper›PMID 34946672›Full record

ArticleMolecules (Basel, Switzerland)2021

Near-Wall Aggregation of Amyloidogenic Aβ 1-40 Peptide: Direct Observation by the FRET.

Natalia Katina, Alisa Mikhaylina, Nelly Ilina, Irina Eliseeva, Vitalii Balobanov

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Natalia KatinaInstitute of Protein Research, Pushchino, 142290 Moscow, Russia.ORCID 0000-0001-6412-1037
Alisa MikhaylinaInstitute of Protein Research, Pushchino, 142290 Moscow, Russia.
Nelly IlinaInstitute of Protein Research, Pushchino, 142290 Moscow, Russia.
Irina EliseevaInstitute of Protein Research, Pushchino, 142290 Moscow, Russia.
Vitalii BalobanovInstitute of Protein Research, Pushchino, 142290 Moscow, Russia.
Institute of Protein Research · RU

Funding

Russian Science Foundation 21-14-00268
6 · The paper itself

Abstract

The formation of amyloid fibrils is one of the variants of the self-organization of polypeptide chains. For the amyloid aggregation, the solution must be oversaturated with proteins. The interface of the liquid (solution) and solid (vessel walls) phases can trigger the adsorption of protein molecules, and the resulting oversaturation can initiate conformational transitions in them. In any laboratory experiment, we cannot exclude the presence of surfaces such as the walls of vessels, cuvettes, etc. However, in many works devoted to the study of amyloid formation, this feature is not considered. In our work, we investigated the behavior of the Aβ 1-40 peptide at the water-glass, water-quartz, and water-plastic interface. We carried out a series of simple experiments and showed that the Aβ 1-40 peptide is actively adsorbed on these surfaces, which leads to a significant interaction and aggregation of peptides. This means that the interface can be the place where the first amyloid nucleus appears. We suggest that this effect may also be one of the reasons for the difficulty of reproducing kinetic data when studying the aggregation of the amyloid of the Aβ 1-40 peptide and other amyloidogenic proteins.

Indexed as

Fluorescence Resonance Energy TransferProtein AggregatesAmyloidAmyloid beta-PeptidesHumansPeptide FragmentsAmyloidAmyloid beta-Peptidesamyloid beta-protein (1-40)Peptide FragmentsProtein AggregatesadsorptionaggregationamyloidogenesisAβ 1-40 peptideboundary of liquid phase

Identifiers

PMID34946672
PMCPMC8706126
OpenAlexW4200582367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.